Eris Lifesciences Share Price
Small Cap | Pharmaceuticals and health care | NSE: ERIS | BSE: 540596
₹1,221.00 
-7.40 (-0.60 %)
Last Updated: 01 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 1,314.80
High (₹) 1,314.80
Low (₹) 1,195.00
Prev. Close (₹) 1,228.40
Volume 3,086
VWAP (₹) 1,235.61
ROCE (%) 11.42
Industry P/E 46.23
TTM P/E 47.70
P/B Ratio 6.52
Market Cap (₹) Cr.16,873.22
Dividend Yield (%)--
EPS (₹) 28.79
ROE15.14%
Sales Growth (%) 19.23
Profit Growth (%)6.12
Day Range
1,314.801,314.80
52 Week Range
810.101,593.00
Historical Returns
Returns (6M)
10.26 %
Returns (1Y)
37.76 %
Returns (3Y)
73.67 %
Returns (5Y)
132.9 %
Returns (6M)
10.26 %
Returns (1Y)
37.76 %
Returns (3Y)
73.67 %
Returns (5Y)
132.9 %
SWOT Analysis
- Company with (2.57%) TTM EPS Growth
- Book value per share improving over the last 2 years
- Company with 2.57% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 39.75
MFI 59.36
ATR 44.69
Commodity Channel Index -39.73
ROC125 8.35
ROC21 -10.63
Williams %R -49.32
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 1,253.16 | 1,277.93 | 1,303.11 | 1,227.98 | 1,203.21 | 1,178.03 | 1,153.26 |
| Week Ago | 1,236.59 | 1,267.22 | 1,286.99 | 1,216.82 | 1,186.19 | 1,166.42 | 1,135.79 |
| Month Ago | 1,387.46 | 1,400.38 | 1,416.61 | 1,371.23 | 1,358.31 | 1,342.08 | 1,329.16 |
EMA & SMA
1221.00
Current Price
Bullish Moving Averages
7
Bearish Moving Averages
13
5 Day 1168.46
9 Day 1217.96
10 Day 1224.79
12 Day 1242.02
14 Day 1241.52
20 Day 1258.61
26 Day 1280.73
50 Day 1354.32
100 Day 1352.52
200 Day 1188.18
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| BHIKHALAL CHIMANLAL SHAH | bulk | Sell | 31 Jan, 2024 | ₹913.09 | 12,80,000 | BSE |
| BHIKHABHAI CHIMANLAL SHAH | bulk | Sell | 29 Apr, 2022 | ₹658.29 | 30,00,000 | BSE |
| EMERALD INVESTMENTS LIMITED | bulk | Buy | 29 Apr, 2022 | ₹658.71 | 28,35,000 | BSE |
| HIMANSHU JAYANTBHAI SHAH | bulk | Sell | 27 Mar, 2020 | ₹360.01 | 19,00,000 | BSE |
| EMERALD INVESTMENTS LIMITED | bulk | Buy | 27 Mar, 2020 | ₹360.00 | 17,94,139 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 18 Aug, 2023 | SABYASACHI SHARMA | Disposal | ₹795.746 | 2,000 | BSE |
| 06 Feb, 2023 | Amit Indubhushan Bakshi | Acquisition | ₹615.0498723404255319148936170 | 11,750 | BSE |
| 23 Jan, 2023 | Amit Indubhushan Bakshi | Acquisition | ₹630.00 | 2,03,000 | BSE |
| 15 Dec, 2022 | Amit Indubhushan Bakshi | Acquisition | ₹663.00 | 3,96,262 | BSE |
| 08 Dec, 2022 | Amit Indubhushan Bakshi | Acquisition | ₹660.7019939393939393939393939 | 1,65,000 | BSE |
| 21 Sept, 2022 | VIJAYA SAMPATH | Disposal | ₹695.925 | 3,400 | BSE |
| 23 Jun, 2022 | Sabyasachi Sharma | Acquisition | ₹451.0400801603206412825651303 | 4,990 | BSE |
| 23 Jun, 2022 | Chetan Doshi | Acquisition | ₹451.0400566457616831883471576 | 4,943 | BSE |
| 26 May, 2022 | Chetan Doshi | Disposal | ₹708.9005 | 2,000 | BSE |
| 23 May, 2022 | SABYASACHI SHARMA | Disposal | ₹713.267 | 3,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 02 Aug, 2022 | Rs.7.3500 per share(735%)Interim Dividend | 11 Aug, 2022 | 16 Aug, 2022 |
| 26 Jul, 2021 | Rs.6.0100 per share(601%)Interim Dividend | 05 Aug, 2021 | 06 Aug, 2021 |
| 04 Aug, 2020 | Rs.5.5000 per share(550%)Interim Dividend | 13 Aug, 2020 | 14 Aug, 2020 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 29 Jan, 2025 | BSE India | Investor meet intimation |
| 29 Jan, 2025 | NSE India | Eris Lifesciences Limited has informed the Exchange about Schedule of meet |
| 29 Jan, 2025 | NSE India | ERIS LIFESCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 04-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . |
| 29 Jan, 2025 | BSE India | Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 ,inter alia, to consider and approve standalone and consolidated unaudited financial results for the quarter & nine months ended 31 December 2024. |
| 20 Jan, 2025 | NSE India | Eris Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
| 20 Jan, 2025 | BSE India | Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018. |
| 24 Dec, 2024 | NSE India | Eris Lifesciences Limited has informed the Exchange about Closure of Trading Window |
| 24 Dec, 2024 | NSE India | Eris Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 09 Dec, 2024 | NSE India | Eris Lifesciences Limited has informed the Exchange regarding Allotment of Securities |
| 09 Dec, 2024 | NSE India | Eris Lifesciences Limited has informed the Exchange regarding allotment of 23490 securities pursuant to ESOP/ESPS at its meeting held on December 09, 2024 |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 30 Jan, 2025 | 04 Feb, 2025 |
| Quarterly Results | -- | 23 Oct, 2024 | 25 Oct, 2024 |
| Quarterly Results | -- | 31 Jul, 2024 | 02 Aug, 2024 |
| Audited Results & Fund Raising | -- | 21 May, 2024 | 21 May, 2024 |
| Quarterly Results | -- | 08 Feb, 2024 | 13 Feb, 2024 |
| Quarterly Results | -- | 02 Nov, 2023 | 08 Nov, 2023 |
| Quarterly Results | -- | 02 Aug, 2023 | 07 Aug, 2023 |
| Audited Results | -- | 11 May, 2023 | 17 May, 2023 |
| Quarterly Results | -- | 11 Jan, 2023 | 17 Jan, 2023 |
| Quarterly Results | -- | 12 Oct, 2022 | 20 Oct, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Eris Lifesciences
Eris Lifesciences is a Public Limited Listed company incorporated on 25/01/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ2007PLC049867 and registration number is 049867. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1486.71 Cr. and Equity Capital is Rs. 13.60 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2007
Managing Director
Mr. Amit Bakshi
NSE Symbol
ERIS
Eris Lifesciences Management
| Name | Designation |
|---|---|
| Mr. Amit Bakshi | Chairperson & Managing Director |
| Mr. Krishnakumar Vaidyanathan | COO & Executive Director |
| Mr. Inderjeet Singh Negi | Executive Director |
| Mr. Kaushal Shah | Executive Director |
| Mr. Rajeev Dalal | Independent Director |
| Mr. Sujesh Vasudevan | Independent Director |
| Ms. Kalpana Unadkat | Independent Director |
| Mr. Prashant Gupta | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,742.20  ₹1,743.95(-0.10%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,618.55  ₹5,577.70(0.73%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,439.50 ₹1,479.40(-2.70%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,481.60 ₹2,435.40(1.90%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,204.95 ₹1,217.35(-1.02%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Eris Lifesciences
What is the share price of Eris Lifesciences?
The share price of Eris Lifesciences on 01 Feb, 2025 is ₹ 1,221.00.
What is 52W high and 52W low share price of Eris Lifesciences?
The highest and lowest 52W share prices of Eris Lifesciences are ₹ 1593.000 and ₹ 810.100
What is the market cap of Eris Lifesciences?
The market capitalization of Eris Lifesciences as of 01 Feb, 2025 is ₹ 16,873.22 Crores
What is the P/E ratio of Eris Lifesciences?
The current P/E ratio of Eris Lifesciences as of 01 Feb, 2025 is 46.23
What is the PB ratio of Eris Lifesciences?
The PB ratio of Eris Lifesciences as of 01 Feb, 2025 is 6.52
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)